• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    2020 ISAM Symposium

    “Updates and Controversies Related to Inhaled Aerosols”

    May 15, 2020 - Philadelphia, PA - Cancelled

    After thoughtful deliberations, the ISAM board has made the difficult decision to cancel the 2020 ISAM symposium set to take place May 15 in Philadelphia, PA. The ISAM leadership has been closely monitoring the spread of COVID-19. Based on the latest guidance from public health officials, the travel bans implemented by different institutions and national emergency declared in the US a few days ago, it became clear to us that canceling was the right course of action.

     

    We thank you for understanding the extreme difficulty of this decision and for your continued support to ISAM. The health and safety of our members and attendees are our top priority. We hope to see you at future events.

     

    Stay well!


     

    Join the International Society for Aerosols in Medicine (ISAM) for a one-day symposium on the latest developments in aerosol inhalation science. The event will take place at the Hilton Garden Inn in Philadelphia Center City and is open to industry, regulatory and academic scientists as well as clinicians and fellows.

     

    Symposium Topics

    • Nanotechnology therapies targeting the lung
    • E-cigarette and their impact on pulmonary health
    • Gene therapy to the respiratory tract
    • pro/con debate: “Do current US requirements for approval of generic orally inhaled products protect patients while preserving incentives for the development of new innovative inhaled therapies?
    • Pre-clinical models of lung diseases

    Call for Abstracts

    We are soliciting abstract and posters that are specific to the symposium topic areas listed above. If you have abstract/posters in these areas – whether submitted to ATS or elsewhere we would love to see them. Submit your abstract posters to cdarquenne@ucsd.edu by April 1, 2020.

    Important Deadlines

    Abstract submission deadline: April 1, 2020
    Early-bird registration deadline: April 15, 2020

    The Venue

    The symposium will take place at the Hilton Garden Inn in Philadelphia Center City, steps away from the Philadelphia Convention Center. The Reading Terminal Market is next door and Independence Hall is minutes away. The hotel is easily accessible being two blocks from Jefferson Station and 13th St. Trolley Station, and 12 miles from the airport. The address of the venue is 1100 Arch Street, Philadelphia, PA 19107, US

     

    Registration Fees (Including coffee breaks, lunch, and reception)

     




     
     EARLY BIRD
    Until April 15, 2020
    After April 15, 2020 
    ISAM Members

    Academia/non-profit: $200
    Industry: $300  
    Academia/non-profit: $250
    Industry: $350  
     Non-ISAM Members Academia/non-profit: $250
    Industry: $350  
    Academia/non-profit: $300 
    Industry: $400 
     Students  $85  $100

    Program Committee

    Chantal Darquenne (University of California, San Diego), David Cipolla (Insmed Inc., USA), Catherine Fromen (University of Delaware, USA), Philip Kuehl (Lovelace Respiratory Research Institute, USA), Jessica Oakes (Northeastern University, USA)

    Program Schedule

    Talks for each session will be a mix of invited speakers and oral presentations selected from submitted abstracts. Please continue to check the website for updates on the program and confirmed invited speakers.

    8:30am-9:30am          

    Registration
    9:00am-9:10am Welcome
    9:10am-10:15am
    Morning session 1: Nanotechnology therapies targeting the lung

    Invited talk 1:
    Nanoparticle Design for Targeting Caveolae and Neutrophils
    Jacob Myerson, PhD,
    University of Pennsylvania, Philadelphia, PA

    Invited talk 2:
    Nanomedicine for Treating ARDS
    Jake Brenner, MD/PhD,
    University of Pennsylvania, Philadelphia, PA
     
    10:15am-10:45am             Coffee break
    10:45am-11:50am

    Morning session 2: Pre-clinical models of lung diseases

    Invited Talk 1:
    Hollow Fiber Model for Lung Infections
    Jakko Van Ingen, MD/PhD
    Radboud UMC, Nijmegen, Netherlands


    Invited talk 2:
    Animal model for IPF
    Mike Beers, MD
    University of Pennsylvania, Philadelphia, PA

    11:50am-12:45pm         Morning session 3: Pro/Con debate: Do current US requirements for approval of generic orally inhaled products protect patients while preserving incentives for the development of new innovative inhaled therapies?

    Pro: Speaker to be confirmed

    Con: Igor Gonda, PhD (Independent consultant)


     
    12:45pm-1:45pm Lunch/Networking

    1:45pm-2:50pm Afternoon session 1: Gene therapy to the respiratory tract

    Invited talk 1:
    Overcoming the mucus barrier to inhaled gene therapy
    Gregg Duncan, PhD,
    University of Maryland, College Park, MD

    Invited talk 2:
    Airway models in gene therapy drug development
    Kate Excoffon, PhD
    Spirovant Sciences, Inc



    2:50pm-3:55pm

    Afternoon session 2: E-cigarettes 
    Invited talk 1:
    Title 
    Frank T. Leone, MD
    University of Pennsylvania, Philadelphia, PA


    Invited talk 2:
    Electronic Cigarettes and Vaping: A Pediatric Perspective 

    Ambika Shenoy, MD.
    Assistant Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University
    Nemours- Alfred I. duPont Hospital for Children, Division of Pulmonology


     

    4:00pm-6:00pm Poster session/Reception/Networking

    Sponsorship

    ISAM welcomes sponsors for this event. Please view our sponsorship information

    Lodging 

    There are many hotels available in downtown Philadelphia. For those attending the American Thoracic Society meeting (May 15-20, 2020, Pennsylvania convention center) the list of ATS recommended hotels can be found here.